EIT Health offers up to €850,000 per project to collaborative consortia developing late-stage digital or AI-enabled medical devices at IML 6 that need clinical validation, regulatory approval and commercialisation support, with applications due by 13 January 2027.
The call focuses on patient-centric digital and AI-powered medical technologies, including digital medical devices and in-vitro diagnostic devices under MDR 2017/745 and IVDR 2017/746, that address critical unmet healthcare needs across screening, diagnosis, treatment and/or monitoring and are ready for clinical validation, regulatory approval and market launch.
Applicants must be legal entities established in an EU Member State, an EU outermost region, an Overseas Country or Territory linked to a Member State, a country associated to Horizon Europe (including the UK), or certain low- and middle-income countries.
Want to discover more opportunities like this?
Join StartupLinkX for free and get matched with relevant funding, competitions, grants, and more.
EIT Health